State Street’s Lisata Therapeutics LSTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $86.2K | Hold |
25,348
| – | – | ﹤0.01% | 3987 |
|
|
2026
Q1 | $127K | Buy |
25,348
+11,000
| +77% | +$45.4K | ﹤0.01% | 3985 |
|
|
2025
Q4 | $26.7K | Hold |
14,348
| – | – | ﹤0.01% | 4221 |
|
|
2025
Q3 | $37.6K | Hold |
14,348
| – | – | ﹤0.01% | 4184 |
|
|
2025
Q2 | $41.3K | Hold |
14,348
| – | – | ﹤0.01% | 4122 |
|
|
2025
Q1 | $33.7K | Hold |
14,348
| – | – | ﹤0.01% | 4144 |
|
|
2024
Q4 | $42.8K | Hold |
14,348
| – | – | ﹤0.01% | 4131 |
|
|
2024
Q3 | $43K | Hold |
14,348
| – | – | ﹤0.01% | 4126 |
|
|
2024
Q2 | $49.8K | Hold |
14,348
| – | – | ﹤0.01% | 4141 |
|
|
2024
Q1 | $44.8K | Hold |
14,348
| – | – | ﹤0.01% | 4182 |
|
|
2023
Q4 | $39.2K | Hold |
14,348
| – | – | ﹤0.01% | 4244 |
|
|
2023
Q3 | $30K | Hold |
14,348
| – | – | ﹤0.01% | 4380 |
|
|
2023
Q2 | $53.1K | Hold |
14,348
| – | – | ﹤0.01% | 4405 |
|
|
2023
Q1 | $46.6K | Hold |
14,348
| – | – | ﹤0.01% | 4517 |
|
|
2022
Q4 | $35.7K | Sell |
14,348
-1
| -0% | -$4 | ﹤0.01% | 4630 |
|
|
2022
Q3 | $66K | Sell |
14,349
-2
| -0% | -$15 | ﹤0.01% | 4588 |
|
|
2022
Q2 | $114K | Hold |
14,351
| – | – | ﹤0.01% | 4468 |
|
|
2022
Q1 | $155K | Buy |
14,351
+420
| +3% | +$4.8K | ﹤0.01% | 4476 |
|
|
2021
Q4 | $176K | Sell |
13,931
-573
| -4% | -$8.85K | ﹤0.01% | 4401 |
|
|
2021
Q3 | $265K | Buy |
14,504
+680
| +5% | +$13.3K | ﹤0.01% | 4250 |
|
|
2021
Q2 | $334K | Buy |
+13,824
| New | +$328K | ﹤0.01% | 4013 |
|
|
2016
Q3 | – | Sell |
-73
| Closed | -$6K | – | 3606 |
|
|
2016
Q2 | $6K | Hold |
73
| – | – | ﹤0.01% | 3714 |
|
|
2016
Q1 | $8K | Hold |
73
| – | – | ﹤0.01% | 3707 |
|
|
2015
Q4 | $12K | Hold |
73
| – | – | ﹤0.01% | 3682 |
|
|
2015
Q3 | $17K | Hold |
73
| – | – | ﹤0.01% | 3670 |
|
|
2015
Q2 | $20K | Sell |
73
-1,858
| -96% | -$690K | ﹤0.01% | 3673 |
|
|
2015
Q1 | $737K | Buy |
1,931
+322
| +20% | +$175K | ﹤0.01% | 3293 |
|
|
2014
Q4 | $910K | Buy |
1,609
+89
| +6% | +$60.6K | ﹤0.01% | 3286 |
|
|
2014
Q3 | $1.26M | Buy |
1,520
+170
| +13% | +$149K | ﹤0.01% | 3186 |
|
|
2014
Q2 | $1.32M | Buy |
1,350
+1,269
| +1,567% | +$1.23M | ﹤0.01% | 3191 |
|
|
2014
Q1 | $86K | Hold |
81
| – | – | ﹤0.01% | 3514 |
|
|
2013
Q4 | $83K | Hold |
81
| – | – | ﹤0.01% | 3496 |
|
|
2013
Q3 | $104K | Hold |
81
| – | – | ﹤0.01% | 3459 |
|
|
2013
Q2 | $68K | Buy |
+81
| New | +$71.1K | ﹤0.01% | 3407 |
|
Other funds holding LSTA
YCM
CL
DAM
RC
VF
GS
State Street's LSTA Position: Q2 2026 in Review
State Street held its Lisata Therapeutics (LSTA) position steady in Q2 2026 at 25,348 shares worth $86.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3987.
State Street first reported a position in LSTA in Q2 2013 and has held it in 34 quarters since. The position peaked at $1.32M in Q2 2014. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.
- State Street held 25,348 shares of Lisata Therapeutics worth $86.2K as of Q2 2026.
- State Street left its Lisata Therapeutics share count unchanged in Q2 2026.
- Lisata Therapeutics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3987 holding.
- State Street first reported a position in Lisata Therapeutics in Q2 2013 and has held it in 34 quarters since.
- State Street's Lisata Therapeutics position peaked at $1.32M in Q2 2014.
- 31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.